American Journal of Clinical Nutrition, Vol 64, 7-11, Copyright © 1996 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Amelioration of the inhibition of fibrinolysis in elderly, obese subjects by moderate energy intake restriction

J Calles-Escandon, D Ballor, J Harvey-Berino, P Ades, R Tracy and B Sobel
Sims Obesity/Nutrition Research Center, University of Vermont, Burlington 05405-0068, USA.

A possible cause of accelerated atherothrombosis in the syndrome of insulin resistance appears to be an elevated blood concentration of plasminogen activator inhibitor type-1 (PAI-1). Insulin resistance occurs with aging, attributable partly to increased adiposity. Scarce information exists regarding the effects of weight loss in elderly, obese individuals on PAI-1 concentrations. Consequently, weight loss (9 +/- 1 kg) was induced by energy intake restriction in 19 elderly, obese individuals, and its effect on fibrinolytic system peptides was measured. Initially elevated PAI-1 concentrations decreased by 50%, with a simultaneous decrease in the concentration of tissue-type plasminogen activator (t-PA)/PAI-1 complexes but no significant change in t-PA suggested a decrease in inhibition of the fibrinolytic system. The concentration of plasmin/antiplasmin complexes (PAP complex) increased by approximately 20%, indicating augmented fibrinolytic system activity. The decline in PAI-1 correlated with that of the decrease in body weight (r = 0.5, P < 0.05) and fat mass losses (r = 0.46, P < 0.05). The increase in PAP complexes correlated with weight and fat mass losses (r = 0.4 and r = 0.46, respectively; P < 0.05 for both). No correlation was seen between fibrinolytic system variables and baseline concentrations of substrates or insulin, but the change in PAI-1 correlated with the change in plasma triacylglycerols (r = 0.58, P < 0.05). Results indicate that energy restriction sufficient to induce moderate weight loss leads to diminution of elevated plasma PAI- 1 and relief of inhibition of the fibrinolytic system in elderly, obese subjects. To the extent that these changes are associated with a decrease in the progression of vasculopathy, weight loss in elderly, obese individuals may be a useful means to reduce cardiovascular morbidity and mortality.

This article has been cited by other articles:

				B. Fletcher, K. Berra, P. Ades, L. T. Braun, L. E. Burke, J. L. Durstine, J. M. Fair, G. F. Fletcher, D. Goff, L. L. Hayman, et al. Managing Abnormal Blood Lipids: A Collaborative Approach Circulation, November 15, 2005; 112(20): 3184 - 3209. [Abstract] [Full Text] [PDF]

				O. Kulaputana, R. F Macko, I. Ghiu, D. A Phares, A. P Goldberg, and J. M Hagberg Human gender differences in fibrinolytic responses to exercise training and their determinants Exp Physiol, November 1, 2005; 90(6): 881 - 887. [Abstract] [Full Text] [PDF]

				Y. Aso, S. Wakabayashi, R. Yamamoto, R. Matsutomo, K. Takebayashi, and T. Inukai Metabolic Syndrome Accompanied by Hypercholesterolemia Is Strongly Associated With Proinflammatory State and Impairment of Fibrinolysis in Patients With Type 2 Diabetes: Synergistic effects of plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor Diabetes Care, September 1, 2005; 28(9): 2211 - 2216. [Abstract] [Full Text] [PDF]

				K. W. Lee and G. Y. H. Lip Effects of Lifestyle on Hemostasis, Fibrinolysis, and Platelet Reactivity: A Systematic Review Arch Intern Med, October 27, 2003; 163(19): 2368 - 2392. [Abstract] [Full Text] [PDF]

				P. A. Ades Cardiac Rehabilitation and Secondary Prevention of Coronary Heart Disease N. Engl. J. Med., September 20, 2001; 345(12): 892 - 902. [Full Text] [PDF]

				N. Barzilai and I. Gabriely The Role of Fat Depletion in the Biological Benefits of Caloric Restriction J. Nutr., March 1, 2001; 131(3): 903S - 906. [Abstract] [Full Text]

				J. Calles-Escandon and M. Cipolla Diabetes and Endothelial Dysfunction: A Clinical Perspective Endocr. Rev., February 1, 2001; 22(1): 36 - 52. [Abstract] [Full Text]

				F. Samad, K. T. Uysal, S. M. Wiesbrock, M. Pandey, G. S. Hotamisligil, and D. J. Loskutoff Tumor necrosis factor alpha  is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1 PNAS, June 8, 1999; 96(12): 6902 - 6907. [Abstract] [Full Text] [PDF]

				M. Cushman, R. N. Lemaitre, L. H. Kuller, B. M. Psaty, E. M. Macy, A. R. Sharrett, and R. P. Tracy Fibrinolytic Activation Markers Predict Myocardial Infarction in the Elderly : The Cardiovascular Health Study Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 493 - 498. [Abstract] [Full Text] [PDF]

				P. A. Sakkinen, M. Cushman, B. M. Psaty, B. Rodriguez, R. Boineau, L. H. Kuller, and R. P. Tracy Relationship of Plasmin Generation to Cardiovascular Disease Risk Factors in Elderly Men and Women Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 499 - 504. [Abstract] [Full Text] [PDF]

				B. E. Sobel, J. Woodcock-Mitchell, D. J. Schneider, R. E. Holt, K. Marutsuka, and H. Gold Increased Plasminogen Activator Inhibitor Type 1 in Coronary Artery Atherectomy Specimens From Type 2 Diabetic Compared With Nondiabetic Patients : A Potential Factor Predisposing to Thrombosis and Its Persistence Circulation, June 9, 1998; 97(22): 2213 - 2221. [Abstract] [Full Text] [PDF]

				D. J. Loskutoff and F. Samad The Adipocyte and Hemostatic Balance in Obesity : Studies of PAI-1 Arterioscler. Thromb. Vasc. Biol., January 1, 1998; 18(1): 1 - 6. [Full Text] [PDF]

				Y. Hong, N. L. Pedersen, N. Egberg, and U. de Faire Moderate Genetic Influences on Plasma Levels of Plasminogen Activator Inhibitor-1 and Evidence of Genetic and Environmental Influences Shared by Plasminogen Activator Inhibitor-1, Triglycerides, and Body Mass Index Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2776 - 2782. [Abstract] [Full Text]

				R. P. Tracy, B. M. Psaty, E. Macy, E. G. Bovill, M. Cushman, E. S. Cornell, and L. H. Kuller Lifetime Smoking Exposure Affects the Association of C-Reactive Protein with Cardiovascular Disease Risk Factors and Subclinical Disease in Healthy Elderly Subjects Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 2167 - 2176. [Abstract] [Full Text]